NCT02144610: A trial that was reported late by AnGes USA, Inc.
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT02144610 |
|---|---|
| Title | A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Oct. 31, 2014 |
| Completion date | March 6, 2017 |
| Required reporting date | March 6, 2018, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | June 22, 2023 |
| Days late | 1934 |